Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2019 | Treating and diagnosing CLL in India

Abraham Varghese • 22 Sep 2019
iwCLL 2019
Chronic Lymphocytic Leukemia Leukemia

Abraham Varghese, MBBS, PhD, Leeds Institute of Cancer, Leeds, UK, describes how the treatment of chronic lymphocytic leukemia (CLL) is changing in India. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

More from Abraham Varghese

4:24
Geographic diversity and the diagnosis & management of CLL in India
Abraham Varghese • 22 Sep 2019

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals